Biogen Inc. buy Morgan Stanley
Start price
10.11.23
/
50%
€209.00
Target price
10.11.24
€349.02
Performance (%)
-12.11%
Price
28.08.24
€183.70
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.11%. This prediction currently runs until 10.11.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -0.649% | -0.649% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Morgan Stanley from $361.00 to $373.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat